Immediate Impact
5 from Science/Nature 76 standout
Citing Papers
Theranostic Fluorescent Probes
2024 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of Mark R. Green being referenced
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark R. Green | 329 | 111 | 57 | 114 | 7 | 418 | |
| Ren-bao Yang | 283 | 102 | 161 | 66 | 9 | 443 | |
| A. Vignoli | 134 | 96 | 74 | 48 | 7 | 485 | |
| Yingjie Shao | 193 | 102 | 101 | 44 | 12 | 476 | |
| Sabrina Thieltges | 325 | 180 | 255 | 65 | 8 | 457 | |
| Ester Fasoli | 146 | 112 | 32 | 36 | 9 | 391 | |
| K. W. Jauch | 214 | 65 | 171 | 51 | 9 | 508 | |
| Martin Brower | 251 | 154 | 49 | 81 | 8 | 475 | |
| Analú Vivian | 159 | 36 | 31 | 42 | 12 | 383 | |
| Marie Pierre Gaub | 124 | 201 | 80 | 41 | 11 | 425 | |
| Jiewen Peng | 237 | 87 | 48 | 162 | 10 | 456 |
All Works
Loading papers...